Potential Health Problems Linked to Ozempic, Wegovy, and Other Weight Loss Drugs Recent studies and reports highlight that Ozempic, Wegovy, and other GLP-1 receptor agonist drugs are associated with serious health risks, including stomach paralysis, also known as gastroparesis, as well as other gastrointestinal issues
Current protocols suggest 5mg administered every 3 days subcutaneously
Phentermine begins with a provider visit and includes regular follow-ups, either in person or via telehealth for patients located in Illinois
Behaviour Research and Therapy, 41(5), 509-528
Additionally, dont take Wegovy or compounded semaglutide if you: Have a prior serious hypersensitivity or allergic reaction to semaglutide or any inactive ingredients Have a history of thyroid cancer Have irritable bowel syndrome (IBS) or severe digestive system disorders Are pregnant or breastfeeding Are under the age of 12 Key takeaway on getting Wegovy or compounded semaglutide for weight loss Semaglutide is the active ingredient in Wegovy, Ozempic, Rybelsus, and compounded semaglutide